...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith shares revalued at Investorline

Noticed today that Zenith shares were revalued at 2.605 CAD at BMO Investorline.  Nice to see that on the balance sheet.  Now hoping that we realize value in our wallets in the near future with a transaction.

masila

Share
New Message
Please login to post a reply